ClinicalTrials.gg
RecruitingNCT03017755Updated Jan 2, 2026

Scoliosis Survey to Development Treatment Decision Tool

An observational study in Scoliosis; Adolescence, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-01-02.

Sponsored by Mayo Clinic · Observational

How we know

From the registry’s dates

  • Started Apr 2017; still recruiting 9 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Ages
13 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Scoliosis with a site in United States — 42 open to participants now, 51 under way, 2 of them phase 3. Scoliosis · United States.

Planned enrollment
3rd of 62
5,000 · median 100
Started
2017
with 4 others
Observational
62 of 153
21 open now
Primary completion
2026-12
later than 14 of 50 live
Registered
82nd of 153
by date
Lead sponsor
5 of 153
Mayo Clinic

Among the 153 studies in Scoliosis with a site in United States, this one is the 3rd largest by planned enrollment of the 62 observational ones that give a count, is one of 5 that started in 2017, is one of 62 observational ones, reaches primary completion later than 14 of the 50 other live ones, and was the 82nd registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

42 of the 153 studies in Scoliosis with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 42 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 13 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Scoliosis with a site in United States, or all of them as a file.
02

Study summary

This is a survey to help understand the influences related to the decision for Adolescent Idiopathic Scoliosis treatment (observation vs. bracing vs. surgery). The investigator then plans to create a decision aid to help families when making a decision about the treatment choice being presented to them.

Read the detailed description

This survey is designed to help understand the factors that families consider to help make treatment decisions related to Adolescent Idiopathic Scoliosis (AIS). The surveys will then be used to help create a shared decision making tool to help families better understand the treatment options and optimize clinical conversations surrounding AIS treatment.

03

Conditions studied

  • Scoliosis; Adolescence

Browse trials for

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adolecent Idiopathic Scoliosis (AIS) patients and their families

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject (and/or parent of subject) who has previously been treated for Adolescent Idiopathic Scoliosis (AIS)

Exclusion criteria

Exclusion Criteria:

  • Age less than or equal to 12 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No

Interventions

  • OtherSurvey for Patients Treated for Scoliosis and ther Families

    Your Scoliosis Journey: A Survey for Patients Treated for Scoliosis and ther Families

06

What researchers measure

Primary outcomes

  1. Number of subjects who completed the survey

    Number of subjects who completed the survey

    Time frame: Baseline, approximately 3 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2017 (actual). Primary completion is estimated for Dec 2026, 115 months after the start.

Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 115 months is above that.

Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2017
First posted
Jan 11, 2017
StartActual
Apr 11, 2017
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 15, 2026
Last update
Jan 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03017755
Lead sponsor
Mayo Clinic
Responsible party
Todd A. Milbrandt, M.D. (MD, Mayo Clinic) — Principal investigator
First posted
Jan 11, 2017
Start date
Apr 11, 2017
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Jan 2, 2026

Study contacts

Damian Paulson
Contact
paulson.damian@mayo.edu
507-293-6713
Todd A Milbrandt, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion